Cargando…
Conjugation with 8-arm PEG and CRM(197) enhances the immunogenicity of SARS-CoV-2 ORF8 protein
Safe and effective vaccines are urgently needed to combat the COVID-19 pandemic. However, the SARS-CoV-2 variants raise concerns about the effectiveness of vaccines. As a SARS-CoV-2 antigen target, ORF8 strongly inhibits the IFN-β and NF-κB-responsive promoter, and can be potentially used for the de...
Autores principales: | Tang, Xiaozhao, Yu, Weili, Shen, Lijuan, Qi, Jinming, Hu, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168007/ https://www.ncbi.nlm.nih.gov/pubmed/35687905 http://dx.doi.org/10.1016/j.intimp.2022.108922 |
Ejemplares similares
-
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
por: Höbel, Sabrina, et al.
Publicado: (2011) -
O:2-CRM(197) Conjugates against Salmonella Paratyphi A
por: Micoli, Francesca, et al.
Publicado: (2012) -
Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide
por: Tobias, Joshua, et al.
Publicado: (2017) -
Safety, Immunogenicity and Dose Ranging of a New Vi-CRM(197) Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults
por: van Damme, Pierre, et al.
Publicado: (2011) -
Site‐Specific Multi‐Functionalization of the Carrier Protein CRM(197) by Disulfide Rebridging for Conjugate Vaccine Development
por: Trattnig, Nino, et al.
Publicado: (2022)